Sources: Alphabet executives nixed a plan to sell robotic arms built by Google's robotics group because they wouldn't be used daily by billions of people
Mark Bergen / Bloomberg :
Context & Ripple Effects
The robotics group had been on an upward arc: published research showed real progress in late 2015 alongside plans to make it a separate Alphabet division, and by January 2016 it was moved into X under ex-Nokia executive Hans Peter Brondmo (relocated to X with a new leader). This report reveals the ceiling on that ambition: when the group built something sellable — robotic arms — Alphabet's leadership blocked commercialization because the product failed a consumer-scale test.
The decision foreshadowed what followed in the corpus: Alphabet later closed the Schaft unit after a sale to SoftBank collapsed, and in 2023 folded Everyday Robots into Google Research. The through-line is a holding company that keeps robotics as research but refuses to ship hardware that can't plausibly serve billions.
First-order effects
- Google's robotics group loses its nearest path to revenue: the arms stay internal, and the team under Brondmo at X remains a research operation rather than a product business.
Second-order effects
- Would-be industrial customers and partners are pushed to other suppliers, and any future divestiture attempts carry the Schaft lesson — Alphabet sought buyers before, and the SoftBank deal collapsed, leaving dissolution as the fallback.
Third-order effects
- If the 'daily use by billions' bar keeps governing Alphabet's portfolio, robotics inside the company is structurally confined to research — confirmed by Everyday Robots' 2023 absorption into Google Research — while commercial robotics migrates to buyers without that constraint.
The trend: Alphabet's moonshot portfolio is being disciplined by a consumer-scale viability test that repeatedly converts robotics from product bets back into research programs.